Early identification of sepsis

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Clinical Diagnostics

Background:

• Sepsis diagnosis relies heavily on early clinical suspicion, requiring thorough patient assessment and identification of infection sources.
• Host response biomarkers, such as acute-phase proteins, procalcitonin, and cytokines, play a role in sepsis diagnosis and management.
• Timely identification of pathogens and their antibiotic resistance is critical for effective sepsis treatment.

Purpose of the Study:

• To review current diagnostic strategies for sepsis.
• To highlight the importance of early clinical suspicion and comprehensive examination.
• To discuss the utility of biomarkers and advanced pathogen detection methods.

Main Methods:

• Review of clinical diagnostic approaches for sepsis.
• Discussion of host response biomarkers (e.g., procalcitonin, cytokines).
• Overview of rapid pathogen detection technologies, including nucleic acid-based methods and antigen detection.

Main Results:

• Early clinical suspicion and examination are foundational for sepsis diagnosis.
• Biomarkers offer supplementary diagnostic and management information.
• Novel techniques like PCR and antigen tests accelerate pathogen identification and susceptibility testing.

Conclusions:

• Integrated diagnostic approaches combining clinical assessment, biomarkers, and rapid molecular diagnostics improve sepsis outcomes.
• Advancements in pathogen detection significantly reduce thời gian to diagnosis and targeted therapy.
• Accurate and swift diagnosis is essential for mitigating sepsis-related morbidity and mortality.